Redesign Health IPO

Redesign Health was founded in 2018 by Brett Shaheen. The company has not publicly endorsed plans to participate in an IPO.

Redesign Health describes itself as "a company that powers innovation in healthcare by developing technologies, tools, and insights that lower the barriers to change across the industry." By offering healthcare startups and entrepreneurs an alternative to traditional VC, Redesign Health helps support innovative medtech companies throughout all stages of growth. Redesign Health has raised more than $300 million in venture capital funding from investors including UPMC Enterprises, TriplePoint Capital, Samsung NEXT, General Catalyst, and Euclidean Capital. The company received a post-money valuation of $1.7 billion in late 2022.

These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

Register for Details

For more details on financing and valuation for Redesign Health, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Redesign Health's ticker symbol?

Redesign Health does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Redesign Health's stock price?

The stock price for Redesign Health will be known as it becomes public. Here are similar public companies: Paypal (NAS: PYPL), Robinhood (NAS: HOOD), E-Trade (NAS: ETFC), Tradeweb (NAS: TW).

Who are Redesign Health's major investors?

General Catalyst
Euclidean Capital
TriplePoint Capital
Samsung NEXT
UPMC Enterprises
Eden Global Partners
CVS Health Ventures
Blisce

Redesign Health Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
9/13/2022 Series C and C-1 $1.68B $XXX.XX $XXX.XX
3/25/2021 Series A and B $454.64MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Redesign Health

What is Redesign Health funding to date?

Redesign Health has raised $162.54MM with the following series:
$454.64MM for Series A and B, $1.68B for Series C and C-1

When was Redesign Health founded?

Redesign Health was founded in 2018.

Can you invest in Redesign Health?

Redesign Health is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Redesign Health share pre-IPO?

If you own Redesign Health pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Is Redesign Health a publicly traded company?

Redesign Health is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Redesign Health in the FinTech sector

Sector
Last Round Est. Valuation
$10.09B
Sector
Last Round Est. Valuation
$506.8MM
Sector
Last Round Est. Valuation
$95B
Sector
Last Round Est. Valuation
$274.59MM
Sector
Last Round Est. Valuation
$24.76B
Sector
Last Round Est. Valuation
$3.94B
Sector
Last Round Est. Valuation
$13.3B
Sector
Last Round Est. Valuation
$5.52B
Sector
Last Round Est. Valuation
$13.4B